Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE), and depresses the cell surface hydrophobicity of oral Candida albicans isolates

Journal of Oral Pathology and Medicine

Volumn 29, Issue 5, 2000, Pages 206-213

  Egusa, H ^a,b   Ellepola, A N B ^a   Nikawa, H ^b   Hamada, T ^b   Samaranayake, L P ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HIROSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Amphotericin B; C. albicans; Hydrophobicity; Minimum inhibitory concentration (MIC); Nystatin; Post antifungal effect (PAFE)

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; NYSTATIN;

ARTICLE; CANDIDA ALBICANS; CELL MEMBRANE; DOSE RESPONSE; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOGENICITY; SCANNING ELECTRON MICROSCOPY; THRUSH; VIRULENCE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; NYSTATIN; VIRULENCE;

EID: 0034055628     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2000.290503.x     Document Type: Article

References (35)

1. Samaranayake LP, Holmstrup P. Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med 1989; 18: 554-64.
2. Feigal DW, Katz MH, Greenspan D. The prevalence of oral lesions in HIV-infected homosexuals and bisexual men: three San Francisco epidemiological cohorts. Aids 1991; 5: 519-25.
3. Craig WA, Gudmundsson S. The postantibiotic effect. In: Lorian V, ed. Antibiotics in laboratory medicine. Baltimore: Williams & Wilkins, 1996; 296-329.
4. Turnidge JD, Gudmundsson S, Vogelman B, et al. The postantibiotic effect of antifungal agents against common pathogenic yeasts. J Antimicrob Chemother 1994; 34: 83-92.
5. Fukazawa Y, Kagaya K. Molecular bases of adhesion of C. albicans. J Med Vet Mycol 1997; 35: 87-99.
6. King RD, Lee JC, Morris AL. Adherence of C. albicans and other Candida species to mucosal epithelial cells. Infect Immun 1980; 27: 667-74.
7. Samaranayake LP, MacFarlane TW. The adhesion of the yeast C. albicans to epithelial cells of human origin in vitro. Arch Oral Biol 1981; 26: 815-20.
8. Samaranayake LP, MacFarlane TW. Factors affecting the in-vitro adherence of the fungal oral pathogen C. albicans to epithelial cells of human origin. Arch Oral Biol 1982; 27: 869-73.
9. Samaranayake YH, Wu PC, Samaranayake LP, So M. Relationship between the cell surface hydrophobicity and adherence of C. krusei and C. albicans to epithelial and denture acrylic surfaces. APMIS 1995; 103: 707-13.
10. Panagoda GJ, Ellepola ANB, Samaranayake LP. Adhesion to denture acrylic surfaces and relative cell-surface hydrophobicity of C. parapsilosis and C. albicans. APMIS 1998; 106: 736-42.
11. Panagoda GJ, Ellepola ANB, Samaranayake LP. Adhesion of C. parapsilosis to epithelial and acrylic surfaces correlates with their cell surface hydrophobicity. Mycoses 2000; 43: in press.
12. McCourtie J, Douglas LJ. Relationship between cell surface composition, adherence and virulence of C. albicans. Infect Immun 1984; 45: 6-12.
13. Calderone RA, Cihlar RL, Lee DD, et al. Yeast adhesion in the pathogenesis of endocarditis due to C. albicans: studies with adherence negative mutants. J Infect Dis 1985; 152: 710-5.
14. Kennedy MJ. Adhesion and association mechanisms of C. albicans. Curr Top Med Mycol 1988; 2: 73-169.
15. Miyaki V, Fujita V, Minagi S, Suginaka H. Surface hydrophobicity and adherence of Candida to acrylic surfaces. Microbiology 1986; 46: 7-14.
16. Macura AB. Hydrophobicity of C. albicans related to their adherence to mucosal epithelial cells. Zentralbl Bakteriol Mikrobiol Hyg [A] 1987; A266: 491-6.
17. Ellepola ANB, Samaranayake LP. Oral candidal infections and antimycotics: A review. Crit Rev Oral Biol Med 2000; 11: in press.
18. Martin MV. Antifungal agents. In: Samaranayake LP, MacFarlane TW, eds. Oral candidosis. London: Wright, 1990; 238-55.
19. Ellepola ANB, Samaranayake LP. The effect of limited exposure to antimycotics on the relative cell surface hydrophobicity and the adhesion of oral C. albicans to buccal epithelial cells. Arch Oral Biol 1998; 43: 879-87.
20. McGinnis MR, Rinaldi MG. Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing and assays of activity in biological fluids. In: Lorian V, ed. Antibiotics in laboratory medicine. Baltimore: Williams & Wilkins, 1996; 176-211.
21. Ellepola ANB, Samaranayake LP. The post-antifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion. Oral Dis 1998; 4: 260-7.
22. Ellepola ANB, Samaranayake LP. The in vitro post-antifungal effect of nystatin on Candida species of oral origin. J Oral Pathol Med 1999; 28: 112-6.
23. Ellepola ANB, Samaranayake LP. In vitro post-antifungal effect (PAFE) elicited by chlorhexidine gluconate on oral isolates of C. albicans. Microbial Ecol Health Dis 1999; 11: 143-8.
24. Sweet SP, MacFarlane TW, Samaranayake LP. Determination of the cell surface hydrophobicity of oral bacteria using a modified hydrocarbon adherence method. FEMS Microbiol Lett 1987; 48: 159-63.
25. Ellepola ANB, Samaranayake LP. Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents. J Oral Pathol Med 1998; 27: 325-32.
26. Ellepola ANB, Samaranayake LP. The effect of limited exposure to antifungal agents on the germ tube formation of oral C. albicans. J Oral Pathol Med 1998; 27: 213-9.
27. Hazen KC, Hazen BW. Dynamic expression of cell surface hydrophobicity during initial cell growth before germ tube formation of C. albicans. Infect Immun 1988; 56: 2521-25.
28. Shibl AM, Ramadan MA, Tawfik AF. Post-antibiotic effect of roxithromycin on streptolysin O production, hydrophobicity and bactericidal activity of PMNL by Streptococcus pyogenes. Diagn Microbiol Infect Dis 1994; 20: 7-11.
29. Ramadan MA, Tawfik AF, Shibl AM, Gemmell CG. Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis. J Med Microbiol 1995; 42: 362-6.
30. Schafer-Korting M, Blechschmidt J, Korting HC. Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular risk. Mycoses 1996; 39: 329-39.
31. Ellepola ANB, Samaranayake LP. Adhesion of oral C. albicans isolates to denture acrylic following limited exposure to antifungal agents. Arch Oral Biol 1998; 43: 999-1007.
32. Ellepola ANB, Panagoda GJ, Samaranayake LP. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin. Oral Microbiol Immunol 1999; 14: in press.
33. Janda JM, Abbott SL. Microbial hydrophobicity; the sticky end things. Clin Microbiol Newslet 1993; 15: 9-16.
34. Hazen KC, Hazen BW. Hydrophobic surface protein masking by the opportunistic fungal pathogen C. albicans. Infect Immun 1992; 60: 1499-508.
35. White TC, Marr KA, Bowden RA. Clinical cellular and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382-402.